Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Morgan Stanley cuts Southern Copper to Underweight, says premium 'unwarranted' » 06:47
08/04/20
08/04
06:47
08/04/20
06:47
SCCO

Southern Copper

$44.15 /

+0.46 (+1.05%)

Morgan Stanley analyst…

Morgan Stanley analyst Carlos De Alba downgraded Southern Copper to Underweight from Equal Weight with a price target of $38, up from $37. The analyst, who sees production remaining range-bound around 1,000kt in the next six years, views the stock's premium valuation compared to peers and its own history as "unwarranted," he tells investors. While he assumes the company will develop three small-scale projects, he thinks they will mostly offset falling production at existing operations, De Alba tells investors.

ShowHide Related Items >><<
SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

08/04/20 Morgan Stanley
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley
06/22/20 JPMorgan
Southern Copper downgraded to Underweight from Neutral at JPMorgan
06/16/20 Goldman Sachs
Southern Copper downgraded to Neutral from Buy at Goldman Sachs
06/08/20 Citi
Southern Copper downgraded to Sell from Buy at Citi
SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

Downgrade
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley » 05:28
08/04/20
08/04
05:28
08/04/20
05:28
SCCO

Southern Copper

$44.15 /

+0.46 (+1.05%)

Morgan Stanley analyst…

Morgan Stanley analyst Carlos De Alba downgraded Southern Copper to Underweight from Equal Weight with a $38 price target.

ShowHide Related Items >><<
SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

06/22/20 JPMorgan
Southern Copper downgraded to Underweight from Neutral at JPMorgan
06/16/20 Goldman Sachs
Southern Copper downgraded to Neutral from Buy at Goldman Sachs
06/08/20 Citi
Southern Copper downgraded to Sell from Buy at Citi
04/07/20 Citi
Alcoa price target lowered to $7 from $14 at Cit
SCCO Southern Copper
$44.15 /

+0.46 (+1.05%)

Over a quarter ago
Downgrade
Southern Copper downgraded to Underweight from Neutral at JPMorgan » 09:15
06/22/20
06/22
09:15
06/22/20
09:15
SCCO

Southern Copper

$37.77 /

+0.88 (+2.39%)

JPMorgan analyst Rodolfo…

JPMorgan analyst Rodolfo Angele downgraded Southern Copper to Underweight from Neutral with a price target of $33, up from $27. The analyst likes the company's "solid asset base" but says the current valuation is "expensive." He believes Latin American commodity investors should be more selective into the second half for 2020.

ShowHide Related Items >><<
SCCO Southern Copper
$37.77 /

+0.88 (+2.39%)

SCCO Southern Copper
$37.77 /

+0.88 (+2.39%)

06/16/20 Goldman Sachs
Southern Copper downgraded to Neutral from Buy at Goldman Sachs
06/08/20 Citi
Southern Copper downgraded to Sell from Buy at Citi
04/07/20 Citi
Alcoa price target lowered to $7 from $14 at Cit
03/25/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
SCCO Southern Copper
$37.77 /

+0.88 (+2.39%)

Downgrade
Southern Copper downgraded to Neutral from Buy at Goldman Sachs » 04:51
06/16/20
06/16
04:51
06/16/20
04:51
SCCO

Southern Copper

$37.25 /

+0.21 (+0.57%)

, GMBXF

Grupo Mexico

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Thiago Ojea downgraded Southern Copper (SCCO) to Neutral from Buy with a price target of $41, down from $47. Southern Copper has an "aggressive" goal to reach 1.5mt of copper output through greenfield and brownfield projects, Ojea tells investors in a research note. The analyst, however, expects the company's volumes to remain broadly flat in the next four years and notes potential greenfield projects could be delayed given community opposition. In addition, Ojea is cautious on the copper price after the recently rally of more than 20% since March. The analyst reiterates a Buy rating on Grupo Mexico (GMBXF) saying the company offers exposure to Southern Copper's "top-tier copper assets at a more attractive valuation."

ShowHide Related Items >><<
SCCO Southern Copper
$37.25 /

+0.21 (+0.57%)

SCCO Southern Copper
$37.25 /

+0.21 (+0.57%)

06/08/20 Citi
Southern Copper downgraded to Sell from Buy at Citi
04/07/20 Citi
Alcoa price target lowered to $7 from $14 at Cit
03/25/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/24/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
GMBXF Grupo Mexico
$0.00 /

+ (+0.00%)

06/08/20 Citi
Grupo Mexico downgraded to Neutral from Buy at Citi
03/25/20 Morgan Stanley
Grupo Mexico upgraded to Overweight from Equal Weight at Morgan Stanley
03/20/20 Bradesco BBI
Grupo Mexico downgraded to Underperform from Outperform at Bradesco
11/21/19 UBS
Grupo Mexico downgraded to Neutral from Buy at UBS
SCCO Southern Copper
$37.25 /

+0.21 (+0.57%)

Downgrade
Southern Copper downgraded to Sell from Buy at Citi » 06:28
06/08/20
06/08
06:28
06/08/20
06:28
SCCO

Southern Copper

$38.98 /

+0.91 (+2.39%)

Citi analyst Alexander…

Citi analyst Alexander Hacking downgraded Southern Copper to Sell from Buy. The analyst believes "Phase 1" of the copper recovery is mostly complete and that stocks in the group no longer offer the "once every 5-10 years" value that was available in March. Southern Copper trades at a 6% yield on $3.00/lb copper, says Hacking, who sees 8%-10% as more appropriate.

ShowHide Related Items >><<
SCCO Southern Copper
$38.98 /

+0.91 (+2.39%)

SCCO Southern Copper
$38.98 /

+0.91 (+2.39%)

04/07/20 Citi
Alcoa price target lowered to $7 from $14 at Cit
03/25/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/24/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/20/20 Bradesco BBI
Southern Copper downgraded to Underperform from Neutral at Bradesco
SCCO Southern Copper
$38.98 /

+0.91 (+2.39%)

Recommendations
Alcoa price target lowered to $7 from $14 at Cit » 06:58
04/07/20
04/07
06:58
04/07/20
06:58
AA

Alcoa

$6.55 /

+0.575 (+9.63%)

, VALE

Vale

$8.11 /

+0.535 (+7.06%)

, SCCO

Southern Copper

$28.45 /

+1.62 (+6.04%)

Citi analyst Alexander…

Citi analyst Alexander Hacking lowered the firm's price target on Alcoa (AA) to $7 from $14 and keeps a Neutral rating on the shares. The analyst updated the company's estimates to reflect Citi's most recent aluminum price forecasts. Hacking sees value in Alcoa shares after the selloff but prefers names low costs and strong balance sheets such as Vale (VALE) and Southern Copper (SCCO).

ShowHide Related Items >><<
AA Alcoa
$6.55 /

+0.575 (+9.63%)

03/24/20 B. Riley Securities
Alcoa downgraded to Neutral from Buy at B. Riley FBR
03/04/20 BofA
Alcoa upgraded to Neutral from Underperform at BofA
02/03/20 JPMorgan
Alcoa pullback an 'attractive' buying opportunity, says JPMorgan
01/17/20 Deutsche Bank
Deutsche Bank upgrades Alcoa to Buy ahead of aluminum inflection
VALE Vale
$8.11 /

+0.535 (+7.06%)

04/01/20 BMO Capital
Vale upgraded to Outperform from Market Perform at BMO Capital
03/30/20 Goldman Sachs
Vale upgraded to Buy from Neutral at Goldman Sachs
03/20/20 Deutsche Bank
Vale upgraded to Buy from Hold at Deutsche Bank
03/17/20 Citi
Vale upgraded to Buy from Neutral at Citi
SCCO Southern Copper
$28.45 /

+1.62 (+6.04%)

03/25/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/24/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/20/20 Bradesco BBI
Southern Copper downgraded to Underperform from Neutral at Bradesco
02/18/20 Morgan Stanley
Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport
Upgrade
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley » 08:48
03/25/20
03/25
08:48
03/25/20
08:48
SCCO

Southern Copper

$26.55 /

+3.08 (+13.12%)

Morgan Stanley analyst…

Morgan Stanley analyst Carlos De Alba upgraded Southern Copper to Equal Weight from Underweight with a price target of $27, down from $31, as he now sees a more positively skewed risk-reward after sharp corrections in the stock and other Latam mining names.

ShowHide Related Items >><<
SCCO Southern Copper
$26.55 /

+3.08 (+13.12%)

03/24/20 Morgan Stanley
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley
03/20/20 Bradesco BBI
Southern Copper downgraded to Underperform from Neutral at Bradesco
02/18/20 Morgan Stanley
Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport
02/18/20 Morgan Stanley
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley
Upgrade
Southern Copper upgraded to Equal Weight from Underweight at Morgan Stanley » 21:06
03/24/20
03/24
21:06
03/24/20
21:06
SCCO

Southern Copper

$26.55 /

+3.08 (+13.12%)

Morgan Stanley analyst…

Morgan Stanley analyst Carlos De Alba upgraded Southern Copper to Equal Weight from Underweight with a $27 price target.

ShowHide Related Items >><<
SCCO Southern Copper
$26.55 /

+3.08 (+13.12%)

03/20/20 Bradesco BBI
Southern Copper downgraded to Underperform from Neutral at Bradesco
02/18/20 Morgan Stanley
Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport
02/18/20 Morgan Stanley
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley
12/17/19 Itau BBA
Southern Copper downgraded to Market Perform from Outperform at Itau BBA
Downgrade
Southern Copper downgraded to Underperform from Neutral at Bradesco » 06:55
03/20/20
03/20
06:55
03/20/20
06:55
SCCO

Southern Copper

$27.15 /

+1.16 (+4.46%)

Bradesco analyst Thiago…

Bradesco analyst Thiago LoFiego downgraded Southern Copper to Underperform from Neutral with a price target of $24, down from $43, after "the most rapid and wild market correction we've ever seen." He has cut his metals price estimates by 10-20% and adopted a more cautious stance in his LatAm Mining coverage as his base case is for a global recession unwinding in the next couple quarters, with a gradual recovery thereafter.

ShowHide Related Items >><<
SCCO Southern Copper
$27.15 /

+1.16 (+4.46%)

02/18/20 Morgan Stanley
Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport
02/18/20 Morgan Stanley
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley
12/17/19 Itau BBA
Southern Copper downgraded to Market Perform from Outperform at Itau BBA
11/15/19 Citi
Citi makes Freeport McMoRan top pick in copper, says 'risk-on' winner
Hot Stocks
Fly Intel: After Hours Movers » 19:05
02/25/20
02/25
19:05
02/25/20
19:05
ACRS

Aclaris Therapeutics

$1.38 /

-0.04 (-2.82%)

, WW

WW

$34.84 /

-2.05 (-5.56%)

, MTDR

Matador

$10.88 /

-1.32 (-10.82%)

, BGS

B&G Foods

$12.78 /

-0.33 (-2.52%)

, ALRM

Alarm.com

$44.82 /

-1.46 (-3.15%)

, NVRO

Nevro

$132.50 /

-3.01 (-2.22%)

, INFN

Infinera

$7.90 /

-0.2 (-2.47%)

, EVH

Evolent Health

$10.18 /

-1.13 (-9.99%)

, PRTK

Paratek Pharmaceuticals

$3.58 /

+0.04 (+1.13%)

, ADMS

Adamas Pharmaceuticals

$4.77 /

-0.47 (-8.97%)

, AKCA

Akcea Therapeutics

$17.09 /

+0.29 (+1.73%)

, SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

, RVLV

Revolve Group

$19.93 /

+1 (+5.28%)

, SUPN

Supernus

$22.93 /

-1.04 (-4.34%)

, PODD

Insulet

$197.03 /

-10.46 (-5.04%)

, SCCO

Southern Copper

$35.05 /

-1.09 (-3.02%)

, TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

, VICR

Vicor

$47.89 /

-0.14 (-0.29%)

, PEN

Penumbra

$176.15 /

-8.13 (-4.41%)

, UIS

Unisys

$15.88 /

-0.405 (-2.49%)

, PLNT

Planet Fitness

$81.51 /

-2.87 (-3.40%)

, SPCE

Virgin Galactic

$33.65 /

-0.51 (-1.49%)

, REAL

RealReal

$14.99 /

+0.03 (+0.20%)

, ORA

Ormat Technologies

$79.94 /

-3.12 (-3.76%)

, IOVA

Iovance Biotherapeutics

$31.61 /

+6.92 (+28.03%)

, EXEL

Exelixis

$19.42 /

-0.76 (-3.77%)

, EVTC

Evertec

$31.36 /

-0.65 (-2.03%)

, CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

, JAZZ

Jazz Pharmaceuticals

$127.50 /

-3.31 (-2.53%)

, CZR

Caesars

$13.33 /

-0.69 (-4.92%)

, AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

, RRGB

Red Robin

$31.32 /

-3.84 (-10.92%)

, VNDA

Vanda Pharmaceuticals

$11.51 /

-0.28 (-2.37%)

, DIS

Disney

$128.24 /

-4.79 (-3.60%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: Aclaris (ACRS) up 8.0%... WW International (WW) up 6.8%... Matador Resources (MTDR) up 6.0%... B&G Foods (BGS) up 5.7%... Alarm.com (ALRM) up 5.3%... Nevro (NVRO) up 3.4%... Infinera (INFN) up 3.4%... Evolent Health (EVH) up 3.1%... Paratek Pharma (PRTK) up 2.8%... Adamas Pharma (ADMS) up 1.9%... Akcea Therapeutics (AKCA) up 1.9%. DOWN AFTER EARNINGS: SmileDirectClub (SDC) down 20.5%... Revolve Group (RVLV) down 18.1%... Supernus Pharma (SUPN) down 15.0%... Insulet (PODD) down 12.1%... Southern Copper (SCCO) down 9.3%... Toll Brothers (TOL) down 9.0%... Vicor Corp (VICR) down 8.7%... Penumbra (PEN) down 6.9%... Unisys (UIS) down 6.1%... Planet Fitness (PLNT) down 5.9%... Virgin Galactic (SPCE) down 5.7%... RealReal (REAL) down 5.1%... Ormat Technologies (ORA) down 3.8%... Iovance Biotherapeutics (IOVA) down 3.1%... Exelixis (EXEL) down 3.1%... Evertec (EVTC) down 3.0%... Salesforce (CRM) down 2.1%... Jazz Pharma (JAZZ) down 1.8%... Caesars (CZR) down 1.6%... Amarin Corp (AMRN) down 1.4%... Red Robin (RRGB) down 1.3%. ALSO LOWER: Vanda Pharma (VNDA) down 7.6% after Phase 3 study of tradipitant did not meet primary endpoint... Disney (DIS) down 1.7% after naming new CEO. Movers as of 18:30ET.

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$1.38 /

-0.04 (-2.82%)

10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform from Market Perform at SVB Leerink
10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform at SVB Leerink
10/22/19 SVB Leerink
Aclaris Therapeutics upgraded to Outperform from Market Perform at SVB Leerink
10/11/19 William Blair
William Blair sees 'significant value disconnect' in Aclaris Therapeutics
WW WW
$34.84 /

-2.05 (-5.56%)

02/21/20
Fly Intel: Top five analyst upgrades
02/21/20 DA Davidson
WW upgraded to Buy from Neutral at DA Davidson
02/21/20 DA Davidson
WW upgraded to Buy from Neutral at DA Davidson
02/04/20
Fly Intel: Top five analyst upgrades
MTDR Matador
$10.88 /

-1.32 (-10.82%)

02/05/20 Tudor Pickering
Matador downgraded to Hold from Buy at Tudor Pickering
10/04/19 Capital One
Matador upgraded to Overweight from Equalweight at Capital One
09/18/19 Williams Capital
Matador initiated with a Buy at Williams Capital
07/23/19 Stephens
Matador upgraded to Overweight from Equal Weight at Stephens
BGS B&G Foods
$12.78 /

-0.33 (-2.52%)

01/22/20 Jefferies
B&G Foods initiated with a Hold at Jefferies
01/22/20 Jefferies
B&G Foods initiated with a Hold at Jefferies
11/01/19 BMO Capital
B&G Foods price target lowered to $20 from $28 at BMO Capital
08/30/19 Credit Suisse
B&G Foods price target lowered to $17 from $19 at Credit Suisse
ALRM Alarm.com
$44.82 /

-1.46 (-3.15%)

01/27/20 Imperial Capital
Alarm.com upgraded to Outperform from In-Line at Imperial Capital
12/01/19 First Analysis
First Analysis reiterates Strong Buy on Alarm.com after meeting management
10/21/19 First Analysis
Alarm.com upgraded to Strong Buy from Outperform at First Analysis
08/09/19 Jefferies
Alarm.com price target lowered to $58 from $66 at Jefferies
NVRO Nevro
$132.50 /

-3.01 (-2.22%)

01/27/20 Morgan Stanley
Nevro price target raised to $142 from $125 at Morgan Stanley
01/27/20 JMP Securities
Nevro price target raised to $150 from $115 at JMP Securities
01/21/20 Wells Fargo
Nevro price target to $144 from $135 at Wells Fargo
01/07/20 Truist
Nevro initiated with a Buy at SunTrust
INFN Infinera
$7.90 /

-0.2 (-2.47%)

01/02/20 Needham
Infinera price target raised to $12 from $10 at Needham
12/16/19 Needham
Infinera price target raised to $10 from $9 at Needham
11/13/19
Fly Intel: Top five analyst upgrades
11/13/19 JPMorgan
Infinera upgraded to Neutral on acquisition execution at JPMorgan
EVH Evolent Health
$10.18 /

-1.13 (-9.99%)

01/23/20 Cantor Fitzgerald
Evolent Health price target raised to $16 from $10 at Cantor Fitzgerald
01/16/20 Canaccord
Evolent Health expects Kentucky contract to be extended, says Canaccord
12/31/19 Piper Sandler
Piper says Passport may be worth significantly more than Evolent paid if KY won
12/24/19 Truist
New Kentucky RFP raises chance of better Evolent Health outcome, says SunTrust
PRTK Paratek Pharmaceuticals
$3.58 /

+0.04 (+1.13%)

01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
12/19/19 SVB Leerink
Paratek should trade 'significantly higher' on BARDA award, says SVB Leerink
11/14/19 H.C. Wainwright
Paratek Pharmaceuticals price target lowered to $18 from $27 at H.C. Wainwright
11/01/19 SVB Leerink
Paratek shares to see 'significant pressure' on UTI setback, says SVB Leerink
ADMS Adamas Pharmaceuticals
$4.77 /

-0.47 (-8.97%)

12/18/19 H.C. Wainwright
Adamas Pharmaceuticals price target lowered to $10 from $30 at H.C. Wainwright
12/17/19 JMP Securities
JMP keeps Outperform rating, $16 target on Adamas based on Gocovri potential
12/17/19 William Blair
Adamas shares undervalued despite ADS-5102 disappointment, says William Blair
12/17/19 Evercore ISI
Adamas' new team can now execute with 'clean slate,' says Evercore ISI
AKCA Akcea Therapeutics
$17.09 /

+0.29 (+1.73%)

01/22/20 Stifel
Akcea LICA data look 'solid,' as expected, says Stifel
10/08/19 BMO Capital
Akcea Therapeutics price target lowered to $39 from $43 at BMO Capital
10/07/19 Stifel
Pfizer deal a 'solid, unexpected' win for Akcea Therapeutics, says Stifel
10/07/19
Akcea Therapeutics upgraded to Outperform on Pfizer partnership at Wells Fargo
SDC SmileDirectClub
$11.33 /

-0.51 (-4.31%)

01/27/20 Stifel
Washington may be headed to teledentistry rules like California's, says Stifel
01/17/20 Loop Capital
SmileDirectClub price target raised to $20 from $15 at Loop Capital
01/15/20 Jefferies
SmileDirect traditional channel entry makes competitive 'noise,' says Jefferies
01/14/20 Stifel
SmileDirectClub wholesale entrance offers 'incremental' sales, says Stifel
RVLV Revolve Group
$19.93 /

+1 (+5.28%)

02/03/20 BMO Capital
Revolve Group initiated with a Market Perform at BMO Capital
12/20/19 KeyBanc
Revolve Group initiated with a Sector Weight at KeyBanc
12/18/19 Guggenheim
Nike, TJX, Capri, Revolve among Guggenheim's top picks in U.S. retail for 2020
12/17/19 B. Riley Securities
Revolve Group initiated with a Buy at B. Riley FBR
SUPN Supernus
$22.93 /

-1.04 (-4.34%)

11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
11/07/19 Stifel
Supernus downgraded to Hold from Buy at Stifel
11/06/19 Jefferies
Jefferies downgrades Supernus to Hold, cuts target to $23 from $46
11/06/19 Jefferies
Supernus downgraded to Hold from Buy at Jefferies
PODD Insulet
$197.03 /

-10.46 (-5.04%)

02/19/20 Piper Sandler
New partnerships expected, but positive, for Insulet, says Piper Sandler
02/13/20 Piper Sandler
Insulet medical device correction will not impact growth, says Piper Sandler
02/06/20 Raymond James
Insulet price target raised to $213 from $158 at Raymond James
01/07/20 Cowen
Cowen sees minimal Q4 earnings risk for diabetes device stocks
SCCO Southern Copper
$35.05 /

-1.09 (-3.02%)

02/18/20 Morgan Stanley
Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport
02/18/20 Morgan Stanley
Southern Copper downgraded to Underweight from Equal Weight at Morgan Stanley
12/17/19 Itau BBA
Southern Copper downgraded to Market Perform from Outperform at Itau BBA
11/15/19 Citi
Citi makes Freeport McMoRan top pick in copper, says 'risk-on' winner
TOL Toll Brothers
$44.28 /

-2.765 (-5.88%)

02/25/20 Truist
Toll Brothers price target raised to $47 from $37 at SunTrust
02/05/20
Fly Intel: Top five analyst upgrades
02/05/20 RBC Capital
Toll Brothers upgraded to Outperform from Sector Perform at RBC Capital
02/05/20 RBC Capital
Toll Brothers upgraded to Outperform from Sector Perform at RBC Capital
VICR Vicor
$47.89 /

-0.14 (-0.29%)

01/07/20 Needham
Vicor Corporation price target raised to $57 from $45 at Needham
11/21/19 Needham
Vicor Corporation price target raised to $45 from $42 at Needham
10/08/19 Needham
Vicor Corporation initiated with a Buy at Needham
08/12/19
Fly Intel: Top five analyst initiations
PEN Penumbra
$176.15 /

-8.13 (-4.41%)

12/04/19 William Blair
Penumbra long-term outlook likely conservative, says William Blair
12/04/19 Canaccord
Penumbra price target raised to $200 from $175 at Canaccord
12/02/19 RBC Capital
Penumbra price target raised to $192 from $174 at RBC Capital
08/07/19 Canaccord
Penumbra weakness would be a buying opportunity, says Canaccord
UIS Unisys
$15.88 /

-0.405 (-2.49%)

02/07/20 Truist
SAIC price target raised to $110 from $100 at SunTrust
12/19/19 Canaccord
Unisys initiated with a Hold at Canaccord
05/23/19 Sidoti
Unisys initiated with a Buy at Sidoti
04/11/19 Truist
Unisys price target lowered to $17 from $20 at SunTrust
PLNT Planet Fitness
$81.51 /

-2.87 (-3.40%)

02/03/20 BMO Capital
Planet Fitness initiated with an Outperform at BMO Capital
01/03/20 Macquarie
Planet Fitness shares 'significantly undervalued', says Macquarie
11/12/19 Imperial Capital
Planet Fitness price target raised to $80 from $72.50 at Imperial Capital
11/08/19 Roth Capital
Planet Fitness price target lowered to $75 from $86 at Roth Capital
SPCE Virgin Galactic
$33.65 /

-0.51 (-1.49%)

02/20/20 Morgan Stanley
Modest correction for Virgin Galactic overdue and 'healthy,' says Morgan Stanley
12/09/19
Fly Intel: Top five analyst initiations
12/09/19 Morgan Stanley
Morgan Stanley cites 'biotech-type risk/reward' in Virgin Galactic initiation
12/09/19 Morgan Stanley
Virgin Galactic initiated with an Overweight at Morgan Stanley
REAL RealReal
$14.99 /

+0.03 (+0.20%)

02/21/20 Raymond James
Raymond James upgrades RealReal to Outperform on positive near-term trends
02/21/20 Raymond James
RealReal upgraded to Outperform from Market Perform at Raymond James
02/03/20 BMO Capital
RealReal initiated with an Outperform at BMO Capital
ORA Ormat Technologies
$79.94 /

-3.12 (-3.76%)

11/11/19 Roth Capital
Ormat Technologies downgraded to Neutral on valuation at Roth Capital
11/11/19 Roth Capital
Ormat Technologies downgraded to Neutral from Buy at Roth Capital
10/24/19
Fly Intel: Top five analyst downgrades
10/24/19 Cowen
Ormat Technologies downgraded to Market Perform from Outperform at Cowen
IOVA Iovance Biotherapeutics
$31.61 /

+6.92 (+28.03%)

02/25/20 Stifel
Iovance among 'more interesting' cell therapy takeout candidates, says Stifel
01/14/20 Piper Sandler
Iovance Biotherapeutics quietly provided 'positive' update, says Piper Sandler
12/18/19 JMP Securities
Iovance Biotherapeutics initiated with an Outperform at JMP Securities
11/21/19 Wells Fargo
Iovance financing concerns misplaced, says Well Fargo
EXEL Exelixis
$19.42 /

-0.76 (-3.77%)

02/11/20 Piper Sandler
Exelixis data 'impressive,' support accelerated approval, says Piper Sandler
02/11/20 Piper Sandler
Exelixis data 'impressive,' support accelerated approval, says Piper Sandler
01/13/20 Truist
Exelixis initiated with a Buy at SunTrust
01/12/20 Piper Sandler
Exelixis shares to trade lower on guidance, says Piper Sandler
EVTC Evertec
$31.36 /

-0.65 (-2.03%)

06/28/19 Susquehanna
Evertec initiated with a Positive at Susquehanna
CRM Salesforce
$181.65 /

-4.26 (-2.29%)

02/21/20 Stifel
Salesforce price target raised to $210 from $195 at Stifel
02/21/20 BMO Capital
Salesforce price target raised to $220 from $210 at BMO Capital
02/21/20 UBS
Salesforce price target raised to $230 from $190 at UBS
02/20/20 RBC Capital
Salesforce price target raised to $230 from $215 at RBC Capital
JAZZ Jazz Pharmaceuticals
$127.50 /

-3.31 (-2.53%)

02/14/20 Truist
Pfenex initiated with a Buy at SunTrust
01/30/20 Craig-Hallum
Avadel Pharmaceuticals initiated with a Buy at Craig-Hallum
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
01/08/20 Goldman Sachs
Jazz Pharmaceuticals initiated with a Neutral at Goldman Sachs
CZR Caesars
$13.33 /

-0.69 (-4.92%)

01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
11/19/19 Morgan Stanley
Eldorado Resorts initiated with an Overweight at Morgan Stanley
08/26/19
VICI Properties raised to Overweight at Morgan Stanley on non-gaming opportunity
07/01/19 Deutsche Bank
Eldorado Resorts price target raised to $74 from $56 at Deutsche Bank
AMRN Amarin
$17.54 /

-0.05 (-0.28%)

02/18/20
Fly Intel: Top five analyst upgrades
02/18/20 Citi
Citi upgrades Amarin to Buy from Neutral after 27% selloff since November
02/18/20 Citi
Amarin upgraded to Buy from Neutral at Citi
01/29/20 Jefferies
Jefferies confident Amarin will win patent trial, sees up to 20% rally
RRGB Red Robin
$31.32 /

-3.84 (-10.92%)

01/15/20 Maxim
Red Robin seeing early signs of turnaround, says Maxim
11/06/19 Loop Capital
Red Robin price target lowered to $33 from $36 at Loop Capital
09/05/19 Stephens
Red Robin back to 'trust me' story after takeover rejection, says Stephens
08/27/19
Fly Intel: Top analyst downgrades
VNDA Vanda Pharmaceuticals
$11.51 /

-0.28 (-2.37%)

11/07/19 Citi
Citi downgrades Vanda to Neutral after 'excessive' post-earnings rally
11/07/19 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
08/01/19
Fly Intel: Top five analyst upgrades
08/01/19 Citi
Citi upgrades Vanda Pharmaceuticals to Buy, says sentiment at 'rock bottom'
DIS Disney
$128.24 /

-4.79 (-3.60%)

02/25/20 Deutsche Bank
Disney price target raised to $147 from $139 at Deutsche Bank
02/24/20 DA Davidson
Hasbro price target lowered to $130 from $139 at DA Davidson
02/12/20 DA Davidson
Akamai price target raised to $115 from $105 at DA Davidson
02/10/20 RBC Capital
Roku Q4 consensus 'reasonable with modest upward bias', says RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.